+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Systemic Inflammatory Response Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Systemic Inflammatory Response Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Anaphylaxis - Pipeline Insight, 2024 - Product Thumbnail Image

Anaphylaxis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Adult-Onset Still Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Adult-Onset Still Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Still's Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Still's Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Allergy Sinus Pain - Pipeline Insight, 2024 - Product Thumbnail Image

Allergy Sinus Pain - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Autoimmune Encephalitis (AE) - Pipeline Insight, 2024 - Product Thumbnail Image

Autoimmune Encephalitis (AE) - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Autoimmune Gastritis - Pipeline Insight, 2024 - Product Thumbnail Image

Autoimmune Gastritis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
Anti-inflammatory - Pipeline Insight, 2024 - Product Thumbnail Image

Anti-inflammatory - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Chronic Gout - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Gout - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Acute Gout Flare - Pipeline Insight, 2024 - Product Thumbnail Image

Acute Gout Flare - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
House Dust Mite Allergy - Pipeline Insight, 2024 - Product Thumbnail Image

House Dust Mite Allergy - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
HIV-associated Lipodystrophy - Pipeline Insight, 2024 - Product Thumbnail Image

HIV-associated Lipodystrophy - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Hair Diseases - Pipeline Insight, 2024 - Product Thumbnail Image

Hair Diseases - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
PD-1 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

PD-1 Inhibitor - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
Uterine Fibroids & Endometriosis - Pipeline Insight, 2024 - Product Thumbnail Image

Uterine Fibroids & Endometriosis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Chronic Refractory Gout - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Refractory Gout - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Endometriosis Pain - Pipeline Insight, 2024 - Product Thumbnail Image

Endometriosis Pain - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Chronic Inducible Urticaria - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Inducible Urticaria - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 50 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more